Pharmafile Logo
Pharmafocus logo
Advanced Search

UK industry code of practice to be reviewed

January 7, 2005
Sales and Marketing

The ABPI has announced a major review of its self-regulated Code of Practice, seeking the views of stakeholders on the …

News

Is the waiting over?

January 7, 2005

Feature

Industry contributes to disaster relief in Asia

January 6, 2005
Sales and Marketing AZ, GSK, WHO, disaster, relief, tsunami

Pharmaceutical companies have joined worldwide efforts to bring relief to areas devastated by the tsunami in Asia, donating money and …

News

Community matrons to manage chronic disease

January 5, 2005

A new role of community matron is to be created to help millions of people with long-term conditions improve their …

News

The weight of evidence – the stories that changed pharma in 2004

January 4, 2005
Research and Development 2004, Vioxx, year in review

Ticking time bombsIn 2004, countries around the world faced up to some home truths about the health of their populations …

Feature

Zocor and the high street revolution

January 4, 2005
Sales and Marketing

It’s an exciting time for consumer healthcare divisions in the pharma industry. Two years ago, the Department of Health (DH) …

Feature

Advert exaggerated Plavix benefits

January 4, 2005
Medical Communications

An advert for anti-clotting drug Plavix has been found in breach of advertising rules because of exaggerated claims of efficacy …

News

Yamanouchi to launch prostate cancer drug Eligard

December 30, 2004
Sales and Marketing

A new treatment for advanced prostate cancer, Eligard, has received approval in 24 European countries and will be marketed by …

News

Avandia advert hypertension claims ‘misleading’

December 30, 2004
Sales and Marketing

Claims that GlaxoSmithKline's diabetes drugs Avandia and Avandamet help to significantly lower blood pressure broke the UK Code of advertising, …

News

Personalised medicine moves a step closer

December 30, 2004
Research and Development, Sales and Marketing

Doctors will be able to use genetic information to determine the best drug dosage for individual patients following approval of …

News

Government hails reduction in NHS red tape

December 21, 2004

News

CAT triumphs in Humira royalty dispute

December 21, 2004
Sales and Marketing

News

Trial data sounds death knell for Iressa

December 21, 2004
Sales and Marketing

AstraZeneca has effectively given up on its cancer drug Iressa, admitting that data from a new large scale trial shows …

News

FDA recommends alternatives following Celebrex scare

December 21, 2004
Sales and Marketing

A new study linking Celebrex to the same increased risk of heart attacks and strokes as recently withdrawn Vioxx has …

News

Watchdog intervenes to sack foundation trust chairman

December 20, 2004

News

AstraZeneca looks to Iressa successor after setback

December 16, 2004
Research and Development

AstraZeneca says it is optimistic about two of its most advanced cancer pipeline drugs, which it hopes will  offset a …

News

Restructured Takeda to go it alone on hypertension drug

December 16, 2004

Takeda is to assume full control of marketing hypertension drug candesartan in the UK from January, ending a seven-year collaboration …

News

Payments by Results could bankrupt hospitals, say doctors’ leaders

December 16, 2004

NHS hospitals that fail to attract patients could become bankrupt under the Payments by Results system, doctors' leaders have warned.Due …

News

Academics raise alarm over trial costs

December 15, 2004

Leading UK academic researchers say extra costs and bureaucracy from new European laws are killing off their work, and have …

News

Taking the plunge

December 10, 2004

When prompted to do some forward thinking, I often start by looking back. In 1999 I was an evangelist for …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025